Jumalon, Jesee C.
HRN: 28-01-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2025
METRONIDAZOLE 500MG (TAB)
10/26/2025
11/02/2025
PO
500mg
TID
AMOEBIASIS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes